125 related articles for article (PubMed ID: 38679840)
1. Treatment at relapse for synovial sarcoma of children and adolescents: A multi-institutional European retrospective analysis.
Ferrari A; Orbach D; Bergamaschi L; Schoot RA; van Noesel MM; Di Carlo D; Bisogno G; Alaggio R; Milano GM; Chiaravalli S; Fuccillo F; Laurence V; Corradini N; Gasparini P; Vennarini S; Pasquali S; Casanova M
Pediatr Blood Cancer; 2024 Jul; 71(7):e31038. PubMed ID: 38679840
[TBL] [Abstract][Full Text] [Related]
2. Synovial sarcoma relapses in children and adolescents: prognostic factors, treatment, and outcome.
Soole F; Maupain C; Defachelles AS; Taque S; Minard-Colin V; Bergeron C; De Rycke Y; Orbach D
Pediatr Blood Cancer; 2014 Aug; 61(8):1387-93. PubMed ID: 24664883
[TBL] [Abstract][Full Text] [Related]
3. Salvage rates and prognostic factors after relapse in children and adolescents with initially localised synovial sarcoma.
Ferrari A; De Salvo GL; Dall'Igna P; Meazza C; De Leonardis F; Manzitti C; De Ioris MA; Casanova M; Carli M; Bisogno G
Eur J Cancer; 2012 Dec; 48(18):3448-55. PubMed ID: 22835783
[TBL] [Abstract][Full Text] [Related]
4. Synovial Sarcoma Recurrence in Children and Young Adults.
Scheer M; Dantonello T; Hallmen E; Blank B; Sparber-Sauer M; Vokuhl C; Leuschner I; Münter MW; von Kalle T; Bielack SS; Klingebiel T; Koscielniak E;
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):618-626. PubMed ID: 27638676
[TBL] [Abstract][Full Text] [Related]
5. Sparing strategy does not compromise prognosis in pediatric localized synovial sarcoma: experience of the International Society of Pediatric Oncology, Malignant Mesenchymal Tumors (SIOP-MMT) Working Group.
Orbach D; Mc Dowell H; Rey A; Bouvet N; Kelsey A; Stevens MC
Pediatr Blood Cancer; 2011 Dec; 57(7):1130-6. PubMed ID: 21495161
[TBL] [Abstract][Full Text] [Related]
6. Synovial sarcoma of children and adolescents: the prognostic role of axial sites.
Ferrari A; Bisogno G; Alaggio R; Cecchetto G; Collini P; Rosolen A; Meazza C; Indolfi P; Garaventa A; De Sio L; D'Angelo P; Tamaro P; Casanova M; Carli M
Eur J Cancer; 2008 Jun; 44(9):1202-9. PubMed ID: 18440800
[TBL] [Abstract][Full Text] [Related]
7. Pediatric and adolescent synovial sarcoma: multivariate analysis of prognostic factors and survival outcomes.
Stanelle EJ; Christison-Lagay ER; Healey JH; Singer S; Meyers PA; La Quaglia MP
Ann Surg Oncol; 2013 Jan; 20(1):73-9. PubMed ID: 22878620
[TBL] [Abstract][Full Text] [Related]
8. Adult-type non-rhabdomyosarcoma soft tissue sarcomas in pediatric age: Salvage rates and prognostic factors after relapse.
Chiaravalli S; Bergamaschi L; Livellara V; Sironi G; Puma N; Nigro O; Gattuso G; Luksch R; Terenziani M; Spreafico F; Meazza C; Podda M; Biassoni V; Schiavello E; Morosi C; Massimino M; Casanova M; Ferrari A
Eur J Cancer; 2022 Jul; 169():179-187. PubMed ID: 35576803
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors and clinical outcomes in synovial sarcoma of the extremities.
Wisanuyotin T; Radapat K; Sirichativapee W; Paholpak P; Kosuwon W; Sumnanoont C; Jeeravipoolvarn P
Asia Pac J Clin Oncol; 2013 Mar; 9(1):80-5. PubMed ID: 22898085
[TBL] [Abstract][Full Text] [Related]
10. Relapse after nonmetastatic rhabdomyosarcoma: Salvage rates and prognostic variables.
Bergamaschi L; Chiaravalli S; Livellara V; Sironi G; Puma N; Nigro O; Gattuso G; Luksch R; Terenziani M; Spreafico F; Meazza C; Podda M; Biassoni V; Schiavello E; Hovsepyan S; Morosi C; Vennarini S; Massimino M; Casanova M; Ferrari A
Pediatr Blood Cancer; 2023 Jan; 70(1):e30050. PubMed ID: 36215173
[TBL] [Abstract][Full Text] [Related]
11. The effect of adjuvant therapies on long-term outcome for primary resected synovial sarcoma in a series of mainly children and adolescents.
Scheer M; Vokuhl C; Bauer S; Fuchs J; Loff S; Timmermann B; Münter M; Henssen AG; Kazanowska B; Niggli F; Ladenstein R; Ljungman G; Koscielniak E; Klingebiel T;
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3735-3747. PubMed ID: 34272609
[TBL] [Abstract][Full Text] [Related]
12. High Response Rates and Promising Outcomes of Patients with Relapsed Ewing Sarcoma, Especially in Adolescents and Young Adults Treated on a Novel Hybrid Salvage Chemotherapy Regimen.
Vijayasekharan K; Ramanathan S; Chinnaswamy G; Prasad M; Gulia A; Janu A; Rekhi B; Ramadwar M; Khanna N; Laskar S; Puranadare N; Bajpai J; Puri A; Banavali S; Vora T
J Adolesc Young Adult Oncol; 2021 Apr; 10(2):185-192. PubMed ID: 32706630
[No Abstract] [Full Text] [Related]
13. Grossly-resected synovial sarcoma treated by the German and Italian Pediatric Soft Tissue Sarcoma Cooperative Groups: discussion on the role of adjuvant therapies.
Brecht IB; Ferrari A; Int-Veen C; Schuck A; Mattke AC; Casanova M; Bisogno G; Carli M; Koscielniak E; Treuner J
Pediatr Blood Cancer; 2006 Jan; 46(1):11-7. PubMed ID: 16292743
[TBL] [Abstract][Full Text] [Related]
14. Synovial Sarcoma in Children, Adolescents, and Young Adults: A Report From the Children's Oncology Group ARST0332 Study.
Venkatramani R; Xue W; Randall RL; Wolden S; Anderson J; Lopez-Terrada D; Black J; Kao SC; Shulkin B; Ostrenga A; Pappo A; Spunt SL
J Clin Oncol; 2021 Dec; 39(35):3927-3937. PubMed ID: 34623899
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors that govern localized synovial sarcoma: a single institution retrospective study on 51 patients.
Yaser S; Salah S; Al-Shatti M; Abu-Sheikha A; Shehadeh A; Sultan I; Salem A; Sughayer M; Al-Loh S; Al-Mousa A
Med Oncol; 2014 Jun; 31(6):958. PubMed ID: 24770952
[TBL] [Abstract][Full Text] [Related]
16. Salvage treatment experience in advanced synovial sarcoma: a multicenter retrospective analysis of the Anatolian society of medical oncology.
Yetisyigit T; Arpaci E; Seber ES; Kucukoner M; Kos FT; Sonmez OU; Alici S; Akman T; Aktas B; Yildiz R; Gunaydin Y; Inanc M; Demirci U; Alkis N; Gumus M
Asian Pac J Cancer Prev; 2013; 14(9):5185-8. PubMed ID: 24175798
[TBL] [Abstract][Full Text] [Related]
17. Synovial sarcoma in children and adolescents: the European Pediatric Soft Tissue Sarcoma Study Group prospective trial (EpSSG NRSTS 2005).
Ferrari A; De Salvo GL; Brennan B; van Noesel MM; De Paoli A; Casanova M; Francotte N; Kelsey A; Alaggio R; Oberlin O; Carli M; Ben-Arush M; Bergeron C; Merks JH; Jenney M; Stevens MC; Bisogno G; Orbach D
Ann Oncol; 2015 Mar; 26(3):567-72. PubMed ID: 25488687
[TBL] [Abstract][Full Text] [Related]
18. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.
Shankar AG; Ashley S; Craft AW; Pinkerton CR
Med Pediatr Oncol; 2003 Mar; 40(3):141-7. PubMed ID: 12518341
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United States.
Pollack SM; Somaiah N; Araujo DM; Druta M; Van Tine BA; Burgess MA; Chawla SP; Seetharam M; Okuno SH; Bohac C; Chen M; Yurasov S; Attia S
Cancer Med; 2020 Jul; 9(13):4593-4602. PubMed ID: 32374488
[TBL] [Abstract][Full Text] [Related]
20. Synovial sarcoma in children and adolescents: thirty three years of experience with multimodal therapy.
Okcu MF; Despa S; Choroszy M; Berrak SG; Cangir A; Jaffe N; Raney RB
Med Pediatr Oncol; 2001 Aug; 37(2):90-6. PubMed ID: 11496345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
